Iterum Therapeutics plc

Stocks

Delayed OTC Markets Other stock markets 12:09:42 2026-06-11 pm EDT			5-day change	1st Jan Change
0.0400 ^USD	0.00%		-28.57%	-88.06%

Apr. 16	Eton Pharmaceuticals, Inc. Announces CFO Changes	CI
Apr. 16	Eton Pharmaceuticals, Inc. Appoints Judith ?Judy? M. Matthews as Executive Vice President, Accounting and Finance	CI

Published on 11/14/2025 at 10:21 am EST - Modified on 11/14/2025 at 11:05 am EST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Hello, and welcome, everyone, to the Interim Therapeutics Third Quarter 2025 Financial Results. My name is Becky and I will be your operator today.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Apr. 16	Eton Pharmaceuticals, Inc. Announces CFO Changes	CI
Apr. 16	Eton Pharmaceuticals, Inc. Appoints Judith ?Judy? M. Matthews as Executive Vice President, Accounting and Finance	CI
Mar. 30	Iterum Therapeutics plc(OTCPK:ITRM.F) dropped from NASDAQ Composite Index	CI
Mar. 27	Iterum seeks court-led dissolution amid cash crisis, inability to raise funds	RE
Mar. 27	Iterum files wind-up petition due to limited cash, inability to raise equity	RE
Mar. 27	Iterum Therapeutics plc Announces Resignation of Judith Matthews as Chief Financial Officer, Effective March 27, 2026	CI
Mar. 27	Iterum Therapeutics plc Announces Resignation of Corey Fishman as Chief Executive Officer, Effective March 27, 2026	CI
Mar. 27	Iterum Therapeutics plc Announces Resignation of Corey Fishman as President, Effective March 27, 2026	CI
Feb. 13	Iterum Therapeutics provides business update	RE
Feb. 13	Iterum Therapeutics plc Provides Business Update	CI
Dec. 23	Iterum Therapeutics provides business update	RE
Dec. 17	Iterum Therapeutics provides business update	RE
Dec. 05	Iterum Therapeutics provides business update	RE
Nov. 24	Iterum Therapeutics Plc's ORLYNVAH Now Available At McKesson	CI
Nov. 24	Iterum Therapeutics plc Receives 510(K) Clearance by the U.S. Food and Drug Administration	CI